Oral colon-targeted responsive alginate/hyaluronic acid-based hydrogel propels the application of infliximab in colitis

Huai, MX; Pei, ML; Pan, JX; Zhu, Y; Chen, YW; Du, P; Duan, YM; Xu, HX; Ge, WS

Pei, ML; Xu, HX; Ge, WS (通讯作者),Tongji Univ, Shanghai Peoples Hosp 10, Dept Stomatol Ultrasound Res & Educ Inst, Sch Med,Central Lab, 301 Yan Chang Zhong Rd, Shanghai 200072, Peoples R China.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2023; 249 ():

Abstract

Currently, commercialized infliximab (IFX) has rapidly propelled the clinical treatment of IBD, however, its inherent attributes, such as off-target e......

Full Text Link